Biosimilar strategic implementation at a large health system
Topics: Implementation
This resource library includes tools and resources such as reports, white papers, news, patient information and downloadable materials related to the biosimilars, specific to multiple sclerosis (MS) and select anti-inflammatory/rheumatological biosimilars. Additionally, it includes key documents needed for your practice such as Medication Use Evaluation (MUE), P&T Committee articles, and checklists to help onboard new and emerging biosimilar products. Simply by clicking on the areas you wish to explore and access these valuable tools and resources.